Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Leone

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of the National Medical Association|November 30, 2006
A case-control study of factors associated with HIV infection among black womenFatu M Forna, Lisa Fitzpatrick, Adaora A Adimora, et al.
Journal of Clinical Microbiology|August 6, 2005
Molecular subtyping of Treponema pallidum from North and South CarolinaVictoria Pope, Kimberley Fox, Hsi Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2011
Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilisArlene C Seña, Mark Wolff, David H Martin, et al.
The Journal of Infectious Diseases|April 21, 2010
A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilisEdward W Hook, Frieda Behets, Kathleen Van Damme, et al.
Sexually Transmitted Diseases|July 18, 2012
Rapid plasma reagin titer variation in the 2 weeks after syphilis therapyKatherine M Holman, Mark Wolff, Arlene C Seña, et al.
Antiviral Therapy|August 26, 2009
Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007Christopher B Hurt, Sandra I McCoy, Joann Kuruc, et al.
The Journal of Infectious Diseases|April 3, 2007
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trialKaren E Mark, Lawrence Corey, Tze-Chiang Meng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2022
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized TrialOlayemi Osiyemi, Stéphane De Wit, Faïza Ajana, et al.
The Journal of Infectious Diseases|September 2, 2025
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Anti-drug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study ResultsPeter Leone, Alejandro Ferro, Charlotte-Paige Rolle, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of the National Medical Association|November 30, 2006
A case-control study of factors associated with HIV infection among black womenFatu M Forna, Lisa Fitzpatrick, Adaora A Adimora, et al.
Journal of Clinical Microbiology|August 6, 2005
Molecular subtyping of Treponema pallidum from North and South CarolinaVictoria Pope, Kimberley Fox, Hsi Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2011
Predictors of serological cure and Serofast State after treatment in HIV-negative persons with early syphilisArlene C Seña, Mark Wolff, David H Martin, et al.
The Journal of Infectious Diseases|April 21, 2010
A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilisEdward W Hook, Frieda Behets, Kathleen Van Damme, et al.
Sexually Transmitted Diseases|July 18, 2012
Rapid plasma reagin titer variation in the 2 weeks after syphilis therapyKatherine M Holman, Mark Wolff, Arlene C Seña, et al.
Antiviral Therapy|August 26, 2009
Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007Christopher B Hurt, Sandra I McCoy, Joann Kuruc, et al.
The Journal of Infectious Diseases|April 3, 2007
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trialKaren E Mark, Lawrence Corey, Tze-Chiang Meng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2022
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized TrialOlayemi Osiyemi, Stéphane De Wit, Faïza Ajana, et al.
The Journal of Infectious Diseases|September 2, 2025
VH3810109 Efficacy, Safety, Pharmacokinetics, and Incidence of Anti-drug Antibodies in Adults With HIV-1 Naive to Antiretroviral Therapy: BANNER Study ResultsPeter Leone, Alejandro Ferro, Charlotte-Paige Rolle, et al.
Pageof 3